
Through the acquisition of Welsh BBI group on Tuesday, Novo Holdings is demonstrating that the diagnostics area is an important field of interest for the Danish life science investor.
It has been seven years since Novo Holdings last took over majority ownership, and according to Christoffer Søderberg and Sibel Arnes from Novo Holdings' Principal Investments team, a lot is happening in this area, which makes it a highly interesting field for Novo Holdings.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app